Flu vaccination rates in the United States have dropped to a 43.8% coverage level for adults and children over six months old, a decline that health officials say poses a serious public health risk. According to recent data from the CDC, the coverage rate for children fell to 50.2% last season, a drop of more than 13% compared to five years ago. Adults fared even worse, with a 41.9% vaccination rate. These numbers continue a troubling trend that accelerated following the COVID-19 pandemic and have left public health experts worried about the coming season.
Several factors are driving this decrease in immunization. Vaccine hesitancy has become a major global health threat, with many people questioning the safety and effectiveness of vaccines. The pandemic amplified public discourse, which may have spread misinformation that now influences attitudes toward routine immunizations. Some individuals who had negative experiences with COVID-19 vaccines have extended those feelings to the annual flu shot. Others are experiencing vaccine fatigue, feeling overwhelmed by constant messaging and changing recommendations.
Misunderstanding vaccine effectiveness also plays a role. Since influenza viruses mutate frequently, the shot is reformulated every year and varies in effectiveness. Some patients mistake this variability for a lack of effectiveness, assuming the vaccine is unnecessary. However, evidence shows the vaccine still prevents illness, severe disease, hospitalization, and death. During the 2023-2024 season, the CDC estimates the vaccine prevented nearly 9.8 million illnesses and nearly 8,000 deaths in the U.S.
Related: User Blocked from Accessing System
Reduced coverage means more people get sick and more vulnerable groups face higher risks. Older adults, young children, pregnant individuals, and those with chronic conditions are particularly susceptible to complications. Widespread illness also strains the health care system, increasing emergency department visits and hospitalizations.
How Pharmacists Can Help
Community pharmacists are uniquely positioned to address this decline. About 90% of Americans live within five miles of a pharmacy, making these professionals highly accessible. Pharmacists are also among the most trusted health care providers and have become de facto experts on vaccinations for many patients. They can use this access to assess immunization gaps and recommend the shot.
One of the most effective tools pharmacists have is the power of a personal recommendation. Studies show that when a health care provider suggests vaccination, patients are much more likely to agree. Pharmacists can use this leverage by engaging patients in individualized conversations, addressing specific safety concerns, and explaining the personal benefits of protection based on the patient’s age or health history.
Related: Transform Your Smile: The Benefits Of Combining General And Cosmetic Dentistry
Pharmacists can also identify high-risk patients during routine prescription checks for conditions like diabetes or heart disease. These individuals should be prioritized for vaccination counseling. Another underused strategy is coadministration, where patients receive multiple vaccines in a single visit. This approach is convenient, offers the same protection, and only slightly increases the risk of mild side effects. Many larger retail chains have systems to streamline this process, but smaller chains have room to improve convenience through online scheduling, walk-in services, and extended hours. Outreach initiatives that place pharmacists at schools or senior centers can also help by bringing vaccinations directly to where people live.
Building a relationship through respectful, patient-centered communication is essential when addressing hesitancy. Rather than dismissing concerns, pharmacists should listen actively and provide clear, evidence-based guidance. Trust in the provider remains one of the biggest factors in a patient’s decision to get vaccinated.
If current trends continue, the burden of influenza could grow significantly over the next few years. As vaccine hesitancy persists and health care systems face ongoing staffing challenges, the reliance on community pharmacists to fill the gap will only increase. The effectiveness of their outreach will depend heavily on their ability to maintain patient trust and adapt to the evolving setting of public health misinformation.
